XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2

Summary of Significant Accounting Policies (Tables)

6 Months Ended

10 Months Ended

12 Months Ended

Jun. 30, 2022

Dec. 31, 2021

Dec. 31, 2021

Schedule of calculation of basic and diluted net income (loss) per ordinary share

The following table sets forth the calculation of basic and diluted earnings per share for the periods indicated based on the weighted average number of common shares outstanding:

		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Numerator
Net loss available to Class A Unit holders		$	(22,131	)		$	(12,725	)		$	(89,617	)		$	(24,334	)
Denominator
Weighted average Class A Units outstanding, basic and diluted			186,500,000				140,109,890				186,500,000				131,160,221
Net loss per Class A Unit
Net loss per Class A Unit, basic and diluted			(0.12	)			(0.09	)			(0.48	)			(0.19	)
Antidilutive securities
Class B Units			27,100,937				7,767,122				27,100,937				7,767,122

The following table sets forth the calculation of basic and diluted earnings per share for the periods indicated based on the weighted average number of common shares outstanding:

		Years Ended December 31,
		2021				2020
Numerator
Net loss available to Class A Unit holders		$	(55,146	)		$	(26,749	)
Denominator
Weighted average Class A Units outstanding, basic and diluted			150,706,849				104,986,301
Net loss per Class A Unit
Net loss per Class A Unit, basic and diluted		$	(0.37	)		$	(0.25	)

Schedule of accrued expenses

Accrued expenses as presented in the Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 consisted of the following (in thousands):

		June 30, 2022				December 31, 2021
Compensation		$	1,545			$	1,832
Clinical study related costs			222				2,031
Accrued legal costs			3,193				964
Manufacturing improvement costs			652				4,164
Other accrued expenses			572				222
Total accrued expenses and other		$	6,184			$	9,213

Accrued expenses which have been presented on the consolidated balance sheets as of December 31, 2021 and 2020 consisted of the following (in thousands):

		December 31, 2021				December 31, 2020
Compensation		$	1,832			$	1,085
Clinical study related costs			2,031				1,154
Facility expansion costs			19				1,709
Accrued legal			964				—
Manufacturing improvement costs			4,164				—
Other accrued expenses			203				548
Total accrued expenses and other		$	9,213			$	4,496

Schedule of estimated useful lives

The estimated useful lives are as follows:

Computer equipment and software		3-5 years
Furniture and equipment		5-7 years
Leasehold improvements		remainder of lease term

The estimated useful lives are as follows:

Computer equipment and software		3-5 years
Furniture and equipment		5-7 years
Leasehold improvements		remainder of lease term

Schedule of fixed assets

Fixed assets consisted of the following (in thousands):

		June 30, 2022				December 31, 2021
Furniture and equipment		$	2,367			$	2,180
Computer equipment and software			719				569
Leasehold improvements			10,538				10,517
Construction in progress			694				351
Less: accumulated depreciation			(3,461	)			(2,259	)
Total fixed assets, net		$	10,857			$	11,358

Fixed assets consisted of the following (in thousands):

		December 31, 2021				December 31, 2020
Furniture and equipment		$	2,180			$	2,011
Computer equipment and software			569				130
Leasehold improvements			10,517				76
Construction in progress			351				7,854
Less: accumulated depreciation			(2,259	)			(1,157	)
Total fixed assets, net		$	11,358			$	8,914

Schedule of intangible asset

The following table summarizes information related to the Company’s assembled workforce intangible asset (in thousands):

		June 30, 2022				December 31, 2021
Gross carrying amount		$	1,073			$	1,073
Accumulated amortization			753				645
Net carrying amount		$	320			$	428

The following table summarizes information related to the Company’s assembled workforce intangible asset (in thousands):

		December 31, 2021				December 31, 2020
Gross carrying amount		$	1,073			$	1,073
Accumulated amortization			645				431
Net carrying amount		$	428			$	642

Social Capital Suvretta Holdings Corp. III [Member]

Schedule of calculation of basic and diluted net income (loss) per ordinary share

At June 30, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheets are reconciled in the following table:

Gross proceeds		$	250,000,000
Less:
Class A ordinary shares issuance costs			(12,479,666	)
Plus:
Accretion of carrying value to redemption value			12,487,990
Class A ordinary shares subject to possible redemption, December 31, 2021			250,008,324
Less: Remeasurement of carrying value to redemption value			(8,324	)
Class A ordinary shares subject to possible redemption, March 31, 2022			250,000,000
Add: Remeasurement of carrying value to redemption value			371,095
Class A ordinary shares subject to possible redemption, June 30, 2022		$	250,371,095

At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

Gross proceeds		$	250,000,000
Less:
Class A ordinary shares issuance costs			(12,479,666	)
Plus:
Increase of carrying value to redemption value			12,487,990
Class A ordinary shares subject to possible redemption		$	250,008,324

Schedule of Class A Ordinary shares reflected in the Balance Sheets

The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):

		Three Months Ended June 30,																Six Months Ended June 30,								For the Period from January 20, 2021 (inception) through June 30,
		2022								2021								2022								2021
		Class A				Class B				Class A				Class B				Class A				Class B				Class A				Class B
Basic and diluted net loss per ordinary share
Numerator:
Allocation of net loss, as adjusted		$	(1,825,123	)		$	(444,891	)		$	—			$	(143	)		$	(5,025,922	)		$	(1,225,117	)		$	—			$	(5,325	)
Denominator:
Basic and diluted weighted average shares outstanding			25,640,000				6,250,000				—				5,500,000				25,640,000				6,250,000				—				5,500,000
Basic and diluted net loss per ordinary share		$	(0.07	)		$	(0.07	)		$	—			$	(0.00	)		$	(0.20	)		$	(0.20	)		$	—			$	(0.00	)

The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):

		For the Period from February 25, 2021 (Inception) Through December 31, 2021
		Class A				Class B
Basic and diluted net loss per ordinary share
Numerator:
Allocation of net loss		$	(1,675,346	)		$	(649,283	)
Denominator:
Basic and diluted weighted average shares outstanding			15,101,877				5,852,751
Basic and diluted net loss per ordinary share		$	(0.11	)		$	(0.11	)

X

- Definition

Disclosure in tabular form of useful lives of property plant and equipment [Table Text Block].

+ References

No definition available.

+ Details

Name:	prok_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock
Namespace Prefix:	prok_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name:	us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (27)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764

+ Details

Name:	us-gaap_TemporaryEquityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	dei_LegalEntityAxis=prok_SocialCapitalSuvrettaHoldingsCorp.IiiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: